Digital Pain Management

Digital tools for the treatment of pain, both acute and chronic, such as apps, implantables, and consumer electronics.

Lux logo LUX TAKE:

The value of digital pain management is in the ability to scale therapeutic care by making it more accessible and cost-effective. There are different approaches to pain management, ranging from pharmaceuticals and surgical interventions, to physical therapies, all the way to therapies for treating the mental and emotional components of pain. Digital tools offer ways to scale established approaches...


Lux Take last updated on August 20, 2020
Data last updated on October 07, 2021

What's New

Lux Research analysts and the Lux Intelligence Engine have added the following recent digital pain management developments.

News Commentaries

Kaia Health raises additional $75 million in Series C for its digital therapeutic platform (May 3, 2021)

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978

© 2004-2021 Lux Research, Inc. All Lux Research content is intended only for consumption by Lux Research clients; redistribution is prohibited and copyright is strictly enforced. All material is based on information obtained from sources believed to be reliable but no independent verification has been made, nor is its accuracy or completeness guaranteed. All material is published solely for informational purposes and is not to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments.